Código QR (código de barras bidimensional)

Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy

Objective: This study is a comprehensive review of the clinical pharmacology, pharmacokinetics, efficacy, safety, and clinical applicability of amivantamab-vmjw for metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion (exon20ins) mutation. Data...

ver descrição completa

Na minha lista:
Principais autores: Vishal Shah, Andrea McNatty, Lacey Simpson, Henry Ofori, Farah Raheem
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2023-03-01
coleção:Biomedicines
Assuntos:
amivantamab-vmjw
lung cancer
EGFR
exon 20
NSCLC
Acesso em linha:https://www.mdpi.com/2227-9059/11/3/950
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados